PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1535746
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1535746
Arabinoxylan Fiber Market Size - By Application (Pharmaceutical, Beverages, Food, Animal Nutrition [[Pet, Poultry, Ruminants, Swine]]), By Source (Barley, Rice, Maize, Oats, Wheat) & Forecast, 2024 - 2032
Global Arabinoxylan Fiber Market will record over 8.5% CAGR from 2024 to 2032, owing to the growing trend towards natural and plant-based ingredients in food products.
There is an increase in consumer awareness of the health benefits associated with natural fibers, including their role in enhancing digestive health and supporting wellness. As more individuals seek healthier and sustainable food options, the demand for arabinoxylan fiber escalates. The broader movement towards clean labels and minimally processed foods is encouraging the F&B players to invest in R&D and introduce new ingredients, further propelling the market growth. For instance, in February 2024, Ingredion launched NOVATION(R) Indulge 2940, a clean-label, non-GMO starch enhancing gelling and mouthfeel in dairy and plant-based products. This innovation offers a natural, corn-based alternative, meeting the demands of health-conscious consumers for indulgent textures.
The overall arabinoxylan fiber market is sorted based on application, source, and region.
The wheat segment will witness a noteworthy CAGR from 2024 to 2032, due to its inherent functional benefits and enhanced nutritional profile. As consumers and manufacturers prioritize whole grain and fiber-rich foods, wheat products fortified with arabinoxylan offer improved health attributes, such as better digestive health and glycemic control. The nutritional trends favoring high-fiber diets contribute to the rising demand for wheat-based arabinoxylan fiber.
The pharmaceuticals segment will capture a notable market share by 2032, driven by the potential therapeutic applications and health benefits of arabinoxylan fiber. As pharmaceutical companies explore natural and plant-based ingredients for drug formulations, the product's role in enhancing drug delivery systems and improving bioavailability becomes significant. It is used in developing dietary supplements and functional foods, offering health benefits such as immune support and gut health. The shift towards incorporating more natural components in pharmaceutical products aligns with consumer preferences for holistic health solutions, thriving demand in the segment.
Europe arabinoxylan fiber market will demonstrate a strong CAGR from 2024 to 2032, owing to a growing focus on health and wellness trends. Consumers in Europe are seeking natural and sustainable dietary solutions, aligning with a preference for fibers that offer health benefits and are derived from renewable sources. The regulatory support for incorporating beneficial fibers in food and supplements is encouraging the adoption of arabinoxylan fiber. This, combined with heightened consumer awareness of the product's role, will favor the market growth in Europe.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Base estimates & calculations
- 1.3 Forecast calculation
- 1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
- 1.4.2.1 Paid sources
- 1.4.2.2 Public sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.1.1 Key manufacturers
- 3.1.2 Distributors
- 3.1.3 Profit margins across the industry
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Low cost raw material availability due to positive trade scenario
- 3.2.1.2 Increasing product usage in bakery application
- 3.2.1.3 Rapid expansion in dietary fibers market along with enhanced focus on NDP
- 3.2.2 Market challenges
- 3.2.2.1 Harmful effect of excessive dietary fiber along with diverse pharmaceutical regulations
- 3.2.3 Market opportunity
- 3.2.3.1 New opportunities
- 3.2.3.2 Growth potential analysis
- 3.2.1 Growth drivers
- 3.3 Raw material landscape
- 3.3.1 Manufacturing trends
- 3.3.2 Technology evolution
- 3.3.2.1 Sustainable manufacturing
- 3.3.2.1.1 Green practices
- 3.3.2.1.2 Decarbonization
- 3.3.2.1 Sustainable manufacturing
- 3.3.3 Sustainability in raw materials
- 3.3.4 Pricing trends (USD/Ton)
- 3.3.4.1 North America
- 3.3.4.2 Europe
- 3.3.4.3 Asia Pacific
- 3.3.4.4 Latin America
- 3.3.4.5 Middle East & Africa
- 3.4 Regulations & market impact
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Company market share analysis
- 4.2 Competitive positioning matrix
- 4.3 Strategic outlook matrix
Chapter 5 Market Size and Forecast, By Source, 2021-2032 (USD Million, Tons)
- 6.1 Key trends
- 6.2 Wheat
- 6.3 Rice
- 6.4 Barley
- 6.5 Oats
- 6.6 Maize
- 6.7 Others
Chapter 6 Market Size and Forecast, By Application, 2021-2032 (USD Million, Tons)
- 5.1 Key trends
- 5.2 Food
- 5.2.1 Bakery
- 5.2.2 Breakfast cereals & snacks
- 5.2.3 Confectionery
- 5.2.4 Dairy
- 5.2.5 Meat products
- 5.2.6 Infant food
- 5.3 Beverages
- 5.4 Pharmaceutical
- 5.5 Animal nutrition
- 5.5.1 Swine
- 5.5.2 Ruminants
- 5.5.3 Poultry
- 5.5.4 Pet
- 5.6 Others (personal care & cosmetics)
Chapter 7 Market Size and Forecast, By Region, 2021-2032 (USD Million, Tons)
- 7.1 Key trends
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Rest of Europe
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 India
- 7.4.3 Japan
- 7.4.4 South Korea
- 7.4.5 Australia
- 7.4.6 Rest of Asia Pacific
- 7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
- 7.6 MEA
- 7.6.1 Saudi Arabia
- 7.6.2 UAE
- 7.6.3 South Africa
- 7.6.4 Rest of MEA
Chapter 8 Company Profiles
- 8.1 Shandong Zhi Shang Chemical Co. Ltd
- 8.2 Nanjing Raymon Biotech Co., Ltd
- 8.3 Acetar Bio-tech Inc
- 8.4 Triumph International Development Limited
- 8.5 Daiwa Pharmaceutical
- 8.6 Megazyme
- 8.7 Antimex Pharmaceuticals & Chemicals Ltd
- 8.8 Comet Biorefining
- 8.9 Cargill
- 8.10 Kowa India Pvt. Ltd
- 8.11 J. Rettenmaier & Sohne GmbH & Co. K
- 8.12 HL Agro
- 8.13 BioActor BV
